Congenital Myelodysplastic Syndrome in a Newborn with Germline JAK2 Variant Treated with Liposomal Cytarabine-Daunorubicin and Allogeneic Hematopoietic Stem Cell Transplant
Title: Congenital Myelodysplastic Syndrome in a Newborn with Germline JAK2 Variant Treated with Liposomal Cytarabine-Daunorubicin and Allogeneic Hematopoietic Stem Cell TransplantAuthors:Kristin E. Zorn1*, Kathleen M. Bone2, Maria E. Hintzke2, Amy Mos
Authors
- Maria Hintzke (ORCID: https://orcid.org/0009-0003-5514-2903)
- Kristin E. Zorn (ORCID: https://orcid.org/0000-0001-5308-8489)
- Zachary Graff (ORCID: https://orcid.org/0000-0003-2617-727X)
- Kathleen M. Bone (ORCID: https://orcid.org/0000-0002-2690-0934)
- Amy Moskop (ORCID: https://orcid.org/0000-0002-5110-004X)
Institutions
- Medical College of Wisconsin (US)
Publication Details
- Published
- 2025-09-01
- DOI
- https://doi.org/10.22541/au.175673362.28057604/v1
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00